The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.51
Bid: 3.02
Ask: 4.00
Change: 0.00 (0.00%)
Spread: 0.98 (32.45%)
Open: 3.51
High: 0.00
Low: 0.00
Prev. Close: 3.51
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Oilex hails milestone with Cambay resolution

Thu, 01st Apr 2021 10:34

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Oilex Ltd, up 52% at 0.25 pence, 12-month range 0.06p-0.25p. The Australian oil & gas exploration and production company says GSPC has provided notification that it has approved the sale of its 55% participating interest in the Cambay PSC to Oilex for USD2.2 million. The transaction has also received the approval of the state government of Gujarat and following completion, Oilex will hold a 100% participating interest in the Cambay PSC. "We are pleased that Oilex and GSPC have been able to work together to agree this outcome and in doing so a major milestone has been achieved by the company in the face of many challenges. The long-awaited resolution provides the company with a pathway to evaluate the significant gas resource potential identified at Cambay," says Managing Director Joe Salomon.

----------

PetroNeft Resources PLC, up 40% at 2.45p, 12-month range 0.5p-3.68p. The Russia-focused oil & gas exploration and production company says total of USD2.7 million of debt converted to equity under three historic convertible loan agreements for the issuance of 115.8 million new shares. "We are very pleased to be able to announce exercise of these conversion rights as it reduces the level of debt of the company by a substantial amount and at the same time demonstrating significant support by the lenders which includes our two largest shareholders along with board directors and senior management," says Chief Executive David Sturt.

----------

Victoria Oil & Gas PLC, up 15% at 4.49p, 12-month range 1.85p-8.15p. The natural gas producing utility says recent weekday production at Cameroon operations has been 5.5 to 6.0 million standard cubic feet per day gross gas, but with the usual daily and weekly fluctuations, with one customer returning having paid off aged debt, and one customer increasing its consumption for both power and thermal. Adds that at Matanda, well planning, procurement of long lead items and rig selection are underway, and the farmout process has been started with several parties registering interest.

----------

AIM - LOSERS

----------

Proteome Sciences PLC, down 16% at 4.23p, 12-month range 2.64p-7p. The drug development services provider reports revenue of GBP4.8 million for 2020, up slightly from GBP4.7 million the year before, and swings to pretax profit of GBP245,000 from loss of GBP36,000. The stock is still up 14% in the year-to-date.

----------

Braveheart Investment Group PLC, down 9.2% at 64p, 12-month range 1.88p-140.2p. Says Chief Executive Trevor Brown sold 2.2 million shares a 74.77p each across Tuesday and Wednesday, with the sale worth GBP1.7 million. He now holds 5.4 million shares, just over a 14% stake.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
29 May 2015 08:01

Proteome Sciences Says It Has Seen "Good Start" To 2015, Loss Widens

Read more
9 Mar 2015 08:40

Proteome Sciences Sees Good Start To 2015 On Contract Signings

Read more
12 Nov 2014 13:06

UK MIDDAY BRIEFING: RBS, HSBC Hit With Fines, Barclays Still In Talks

Read more
12 Nov 2014 12:02

UK WINNERS & LOSERS: G4S And Tullow Oil Lead FTSE 100 Gainers

Read more
12 Nov 2014 12:00

Proteome slides after warning on revenues

Shares in Proteome fell sharply on Wednesday after the group warned its revenue for the current year will be lower than market expectations and "somewhat" lower than the revenues achieved in 2013. The protein biomarker group explained that it had seen a continuation of the previously flagged delay t

Read more
12 Nov 2014 09:27

Proteome Says Revenue Will Not Meet Market Expectations

Read more
30 Sep 2014 09:41

Proteome Appoints Geoffrey Ellis As Finance Director, Loss Widens

Read more
26 Sep 2014 07:21

UK MORNING BRIEFING: De La Rue, Shanks Issue Profit Warnings

Read more
26 Sep 2014 07:03

Proteome Sees "Excellent" Toxicity Test Results For Alzheimer's Drugs

Read more
25 Sep 2014 15:29

Proteome Sciences wins $2m biomarker deal

teerngasAIM biotech Proteome Sciences has been signed up to provide to develop diagnostic products for Alzheimer's disease group Genting TauRx Diagnostic, worth $2m in upfront and milestone payments. Proteome's biomarker services division will analyse blood samples from patients enrolled in a phase

Read more
25 Sep 2014 12:15

REPEAT: UK MIDDAY BRIEFING: Glaxo Appoints Philip Hampton As Next Chairman

Read more
25 Sep 2014 12:09

UK MIDDAY BRIEFING: Glaxo Appoints Ex-RBS Head As Non-Exec Chairman

Read more
25 Sep 2014 11:43

UK WINNERS & LOSERS: 5G Deal Boosts Vodafone Shares

Read more
25 Sep 2014 09:58

Proteome Unit Wins Alzheimer's Diagnostics Contract With Genting TauRx

Read more
8 Jul 2014 17:00

DIRECTOR DEALINGS: Proteome Sciences Non-Executive Buys Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.